Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...

Fosun Pharmaceutical Group has agreed to sell its entire stake in United Family Healthcare to Calcite Gem Investments Group ...

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

SHANGHAI -- Chinese drugmaker Fosun Pharmaceutical Group has agreed to sell its stake in a hospital group to U.S. private equity firm Warburg Pincus for $124.08 million.

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding ...

FOSUN PHARMA (02196.HK) recently released internally its self-developed PharmAID decision agent platform, which is currently constructing a full lifecycle intelligent decision-maki... FOSUN PHARMA ...

According to NSE bulk deal data, Vanguard Emerging Markets Stock Index Fund A Series of VIEIF purchased 0.83 million shares ...